- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01283854
The Cycle Study: a Study of the Effectiveness of Cycling Exercise in Breaking the Cycle of Pregnancy Diabetes
Preventing Gestational Diabetes Mellitus Using a Home-based Supervised Exercise Program During Pregnancy
Gestational diabetes mellitus (GDM) is one of the most common medical complications of pregnancy and has serious health implications for both the pregnant woman and her child. In particular, offspring of mothers with GDM have an increased prevalence of obesity, diabetes and metabolic syndrome, perpetuating serious health consequences in subsequent generations.
Although regular exercise offers numerous benefits for both the mother and her child, its effectiveness in preventing GDM remains to be established. It has been recently shown that regular supervised home-based exercise may attenuate the decline in glucose tolerance in obese pregnant women. This study aims to conduct a single-centred, multi-sited, single-blinded randomised controlled trial examining the effect of 14 weeks of supervised home-based exercise (commenced at 14 weeks gestation) on the recurrence and severity of GDM, along with other aspects of maternal and fetal wellbeing.
Eligible participants (n = 200) will be randomly allocated to an exercise intervention (n = 100) or a control group (n = 100). The exercise intervention will involve three 60-minute home-based, supervised exercise sessions each week. This type of program overcomes many of the barriers to exercise in this population including transportation, child care issues and embarrassment associated with exercising in a public venue. The investigators have already shown this program to be both feasible and warmly accepted by obese pregnant women.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Western Australia
-
Perth, Western Australia, Australia, 6008
- King Edward Memorial Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- women at 12-13 weeks gestation, with a history of gestational diabetes in a previous pregnancy.
Exclusion Criteria:
- unable to participate in the supervised 14 week home-based exercise program
- less than 18 years of age
- unable to understand the implications of participation in the trial
- women with a multiple pregnancy
- women with pre-existing diabetes (type 1 or 2) or cardiac disease
- women currently engaged in a structured exercise program
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Exercise group
Each participant randomised to the exercise group will receive routine, regular antenatal care.
In addition, these women will be required to participate in three 60-minute exercise sessions each week, starting at 14 weeks gestation, for a total of 14 weeks (i.e. to be completed by 28 weeks of gestation).
All exercise sessions will be home-based and fully supervised by an experienced exercise physiologist.
|
Each participant randomised to the exercise group will be required to participate in three 60-minute exercise sessions each week, starting at 14 weeks gestation, for a total of 14 weeks (i.e. to be completed by 28 weeks of gestation). All exercise sessions will be home-based and fully supervised by an experienced exercise physiologist. The exercise program will be implemented in accordance with the American College of Sports Medicine and the American College of Obstetrics and Gynecology guidelines. All sessions will be conducted on a stationary cycle ergometer. Heart rate will be measured continuously during exercise to ensure that the exercise intensity is maintained as prescribed. In addition, blood pressure and rate of perceived exertion will be monitored at 10-min intervals. Perceived exertion will not be allowed to exceed a rating of 14 (i.e. "somewhat hard"). |
|
No Intervention: Control group
Women allocated to the control group will not participate in the home-based exercise program, and will continue their normal physical activity throughout pregnancy.
This group will receive routine, regular antenatal care, together with the additional outcome assessments at baseline (14 weeks gestation) and cessation of the study (28 weeks gestation).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Diagnosis of gestational diabetes mellitus
Time Frame: After the 14 week intervention period (28 weeks gestation)
|
After the 14 week intervention period (28 weeks gestation)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Insulin sensitivity and glucose tolerance
Time Frame: Pre and post-intervention (14 and 28 weeks of gestation)
|
Pre and post-intervention (14 and 28 weeks of gestation)
|
|
Maternal aerobic fitness levels
Time Frame: Pre and post-intervention (14 and 28 weeks gestation)
|
Pre and post-intervention (14 and 28 weeks gestation)
|
|
Maternal morphology (girths and skinfold measures)
Time Frame: Pre and post-intervention (14 and 28 weeks gestation)
|
Pre and post-intervention (14 and 28 weeks gestation)
|
|
Maternal mental health
Time Frame: Pre and post-intervention (14 and 28 weeks gestation)
|
Pre and post-intervention (14 and 28 weeks gestation)
|
|
Obstetric outcomes (rates of medical intervention during labour, birth weight, newborn anthropometrics and incidence of newborn hypoglycemia)
Time Frame: At time of delivery (approximately 40 weeks gestation)
|
At time of delivery (approximately 40 weeks gestation)
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: John Newnham, The University of Western Australia
- Principal Investigator: Paul Fournier, The University of Western Australia
- Principal Investigator: Kym Guelfi, The University of Western Australia
- Principal Investigator: Robert Grove, The University of Western Australia
- Principal Investigator: Karen Wallman, The University of Western Australia
- Principal Investigator: Dorota Doherty, Women and Infants Research Foundation
Publications and helpful links
General Publications
- Ong MJ, Guelfi KJ, Hunter T, Wallman KE, Fournier PA, Newnham JP. Supervised home-based exercise may attenuate the decline of glucose tolerance in obese pregnant women. Diabetes Metab. 2009 Nov;35(5):418-21. doi: 10.1016/j.diabet.2009.04.008. Epub 2009 Sep 10.
- Guelfi KJ, Ong MJ, Crisp NA, Fournier PA, Wallman KE, Grove JR, Doherty DA, Newnham JP. Regular Exercise to Prevent the Recurrence of Gestational Diabetes Mellitus: A Randomized Controlled Trial. Obstet Gynecol. 2016 Oct;128(4):819-827. doi: 10.1097/AOG.0000000000001632.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1003302_Newnham
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gestational Diabetes Mellitus
-
UPECLIN HC FM Botucatu UnespCompletedGestational Diabetes Mellitus | Pregestational Diabetes Mellitus | Mild Gestational HyperglycemiaBrazil
-
IRCCS Burlo GarofoloCompletedGestational Diabetes | Gestational Diabetes Mellitus | Pregnancy-Induced Diabetes | Diabetes Mellitus, Gestational | Diabetes, Pregnancy InducedIsrael, Italy, Netherlands, Slovenia, Sri Lanka
-
University of California, San FranciscoSan Francisco Department of Public Health; San Francisco General Hospital; Sonoma...CompletedType 2 Diabetes Mellitus | Gestational Diabetes MellitusUnited States
-
University of California, Los AngelesRecruitingGestational Diabetes Mellitus in PregnancyUnited States
-
i-Health, Inc.CompletedGestational Diabetes Mellitus in PregnancyGermany
-
The Danish Center for Strategic Research on Type...Odense University HospitalCompletedGestational Diabetes Mellitus in PregnancyDenmark
-
Services Institute of Medical Sciences, PakistanCompletedGestational Diabetes Mellitus in PregnancyPakistan
-
Danone Asia Pacific Holdings Pte, Ltd.Nutricia ResearchTerminatedGestational Diabetes Mellitus in PregnancySingapore
-
Athabasca UniversityCompletedDiabetes Mellitus Gestational Previous PregnancyCanada
-
Hospital Arnau de VilanovaCompletedGestational Diabetes Mellitus (GDM)Spain
Clinical Trials on Supervised home-based exercise
-
University Health Network, TorontoCompletedProstate CancerCanada
-
University Health Network, TorontoTom Baker Cancer Centre; Southlake Regional Health Centre; Scarborough Rouge...Completed
-
Singapore General HospitalRecruitingFrail Elderly Syndrome | Frailty | SurgerySingapore
-
Paracelsus Medical UniversityLudwig Boltzmann Institute for Digital Health and PreventionCompleted
-
Universidade Federal de Santa MariaCompletedOsteoarthritis, KneeBrazil
-
University of Sao Paulo General HospitalCompletedStroke | Cerebrovascular Disorders | Brain Ischemia | Brain InfarctionBrazil
-
Acibadem UniversityCompleted
-
McMaster UniversityHamilton Health Sciences Corporation; Heart and Stroke Foundation of OntarioCompletedCongestive Heart FailureCanada
-
Nordsjaellands HospitalNot yet recruitingUrinary Tract Infections | Community-acquired PneumoniaDenmark
-
Norwegian University of Science and TechnologyVestre Viken Hospital Trust; University Hospital of North Norway; St. Olavs Hospital and other collaboratorsActive, not recruiting